Cleared Traditional

K170888 - Renovis S141 Lumbar Interbody Fusion System

K170888 is an FDA 510(k) clearance for Renovis S141 Lumbar Interbody Fusion System, manufactured by Renovis Surgical Technologies. The device is a Class 2 Orthopedic device with product code MAX cleared through the Traditional 510(k) pathway after a 134-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
134d
Days
Class 2
Risk

K170888 is an FDA 510(k) clearance for the Renovis S141 Lumbar Interbody Fusion System. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Renovis Surgical Technologies (Redlands, US). The FDA issued a Cleared decision on August 8, 2017 after a review of 134 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Renovis Surgical Technologies devices

FDA 510(k) Submission Details - K170888

510(k) Number K170888 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 2017
Decision Date August 08, 2017
Days to Decision 134 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d slower than avg
Panel avg: 122d · This submission: 134d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MAX Device Classification - Class 2, Special Controls

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

MEDIcept, Inc.
Sharyn Orton

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 849
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K170888.
Altus Spine Titanium Interbody Fusion System
K171329 · Altus Partners, LLC · Aug 2017
Duo Lumbar Interbody Fusion Device
K171660 · Spineology, Inc. · Aug 2017
ShurFit 2C Lumbar Interbody Fusion System
K171657 · Precision Spine, Inc. · Aug 2017
Anterior Spine Truss System (STS) Interbody Fusion Device
K170851 · 4Web, Inc. · Aug 2017
The TiBow Expandable Spacer System
K170919 · Life Spine, Inc. · Aug 2017
LumFuse-TP
K171630 · Precifit Medical, Ltd. · Jul 2017